Answers are grounded in this paper and cite their sources.
The current research explored the phytochemical profile, antioxidant activity, metal chelation and molecular docking interactions of Basella alba methanolic extract. Phytochemical analysis demonstrated the occurrence of alkaloids, steroids, saponins, carbohydrates, tannins and reducing sugars. Twelve unique bioactive compounds were identified using GC-MS, with 13-docosenamide (Z)- as the principal component (83.88% area). Antioxidant activity was evaluated using DPPH and FRAP assays. The methanolic extract had a moderate antioxidant activity with IC₅₀ values of 83.26 µg/mL and 46.25 µg/mL for DPPH and FRAP respectively, in comparison to 30.32 µg/mL and 35 µg/mL for ascorbic acid. Metal chelation assays revealed less chelating capacity in the extract (IC₅₀ ≈ 95 µg/mL) compared to the standard (IC₅₀ ≈ 55 µg/mL). Molecular docking identified that certain compounds such as N-(t-butyl)-2-benzoylbenzamide and benzeneethanamine derivatives exhibited potent binding affinities to apoptosis-regulating protein 8CPR with favorable pharmacokinetic and bioavailability profiles. The results justify the therapeutic potential of Basella alba in oxidative stress and cancer-related pathways.
No takes yet. Share an insight, caveat, or question.
Asha et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: